Product Name: Human PDCD1 / PD-1 / CD279 Antibody (Sasanlimab, Research Use)
Catalog Number: NBR-0843
Target Name: PDCD1 / PD-1 / CD279
Trade Name: Sasanlimab
Antibody Drug Description: Sasanlimab (sah-SAN-lih-mab) is a monoclonal antibody to programmed cell death protein 1 (PD-1) and a new experimental drug for cancer treatment that is currently not approved for sale or for use outside of a clinical trial. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: PDCD1
Synonyms: CD279; hSLE1; PD-1; PD1; SLEB2
Target Description: Inhibitory receptor on antigen activated T-cells that plays a critical role in induction and maintenance of immune tolerance to self. Delivers inhibitory signals upon binding to ligands CD274/PDCD1L1 and CD273/PDCD1LG2. 
Ensembl: ENSG00000188389
Uniprot: Q15116